122 results
Page 4 of 7
425
71pp4gxu90afsngcel
24 Jun 20
Business combination disclosure
4:03pm
425
cl4 dq4qs
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
7jhrvw0sq3o0dtvhn8
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
kanru6 7bu
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
195tyiq6x f5k3tod0r
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
8-K
EX-1.1
0h3o2p0aeb
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.1
oij7 76872bgs7ccbq
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.2
3w5ja pu197
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
63de8
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
EX-99.1
egeu4xdhfjgvhurs1
13 Jan 20
Results of Operations and Financial Condition
5:11pm
8-K
EX-99.1
irom9fmmnyv8djiuh
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K/A
EX-99.1
u9kdu
27 Sep 19
Financial Statements and Exhibits
4:16pm
8-K/A
EX-99.2
jwxmtv2w 7e
27 Sep 19
Financial Statements and Exhibits
4:16pm
8-K/A
EX-99.1
dfqkrffb sinyry
28 Aug 19
Statement of Operations
4:05pm